| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 06/06/2006 | US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 06/06/2006 | US7056376 Printing an image on a substrate comprising applying thereto a formulation comprising a liquid medium and a compound containing azo groups and metallized 1,8-dihydroxynaphthyl group |
| 06/06/2006 | CA2154572C Use of riluzole for the treatment of neuro-sida |
| 06/06/2006 | CA2136356C 1,2,3-triazole and imidazole compounds and their antitumor use |
| 06/01/2006 | WO2006057152A1 Therapeutic agent for diabetes comprising protease-inhibiting compound |
| 06/01/2006 | WO2006056488A1 Symmetrical cationic tetraazo compounds, for dyeing keratin fibres |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116366 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660457A1 Ionic liquids based on imidazolium salts incorporating a nitrile functionality |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1461345B1 Copper deposition using copper formate complexes |
| 05/31/2006 | EP1341743B1 Organic reactions with co generating materials |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | CN1781021A N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 05/31/2006 | CN1780617A Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053223 Inhibitors of farnesyl protein transferase |
| 05/30/2006 | US7053221 Heteroatom-stabilized carbenes and precursors thereto as depolymerization catalysts |
| 05/30/2006 | US7053220 For therapy and prophylaxis of neurological disorders associated with beta -amyloid peptide; Alzheimer's disease |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053114 A modulator controls the activity of protein kinases, tyrosine kinase; enzyme inhibitors; nontoxic, solubility, formulability, bioavailability; cancer, diabetes, hepatic cirrhosis, atherosclerosis, angiogenesis, autoimmune disease and renal disease |
| 05/30/2006 | US7053112 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7052783 Also triazine and 2H-tetrazole tetramers; electron transporting layers for electroluminescence devices |
| 05/30/2006 | US7052677 Substituted octanuclear pyrazolato clusters with electron transfer and MRI contrast agent properties |
| 05/30/2006 | CA2141692C Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
| 05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | CA2585378A1 Anthranilamide insecticides |
| 05/25/2006 | US20060111339 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 05/25/2006 | US20060111329 Anticancer Agents Based on Regulation of Protein Prenylation |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1334106B1 Imidazole derivatives, production method thereof and use thereof |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775763A Carboxyl acylamide compound and its preparing method and use |
| 05/24/2006 | CN1257162C SARS coronavirus 3CL protease inhibitor and its use |
| 05/23/2006 | US7049332 Effective against mutations; such as 2,3-Dihydro-4-ethyl-1-(3-methylphenylamino)-5-phenyl-1H-imidazole-2-thione |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/23/2006 | US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | WO2006051897A1 Ionic liquid and its production method, method for forming oxide film on metal surface, electrolytic capacitor and electrolyte |
| 05/18/2006 | WO2006051772A1 Liquid electrolyte |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106226 Isolation of amino acids and related isolates |
| 05/18/2006 | US20060105435 Process for producing optically active alpha-methylcysteine derivative |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1516021B1 Printing process using specified azo compounds |
| 05/17/2006 | EP1007729A4 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 05/17/2006 | CN1774452A Polymerisation initiator system |
| 05/17/2006 | CN1774424A 1-imidazolylmethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing |
| 05/17/2006 | CN1772740A Antifungal Compound und its prepn process and application |
| 05/16/2006 | US7045608 Process for the preparation of cationic azo compounds |
| 05/16/2006 | US7045536 Compound having anti-viral activity |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2208731C Silicate-, borate- and nitrate-free antifreeze concentrates and coolant compositions comprising them |
| 05/11/2006 | WO2006049014A1 PROCESS FOR PRODUCING α,α-DIFLUOROAMINE |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2006035960A3 Process for production of 2-chloro-4-nitroimidazole |
| 05/11/2006 | WO2005086892A3 Ion channel modulators |
| 05/11/2006 | WO2005072082B1 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 05/11/2006 | US20060100219 Dihydroimidazoles and tetrahydropyrmidines containing amide and sulfonamide groups, e.g., 3-[(2,3-Dichlorobenzenesulphonyl)methylamino]-N-{2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl}-N-methylpropionamide; treating pain, skin disease, irritable bladder or colon, asthma, COPD, and stomach inflammation |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | DE102004054053A1 New 2-(hetero)aryl-imidazoline or tetrahydropyrimidine derivatives, are bradykinin B1 receptor antagonists used e.g. for treating neuropathic or inflammatory pain or migraine |
| 05/11/2006 | CA2585645A1 Ceramides and apoptosis-signaling ligand |
| 05/11/2006 | CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | CA2580363A1 Compositions for controlled delivery of pharmaceutically active compounds |
| 05/10/2006 | EP1655303A2 Hydroxylamine esters as polimerization initiators |
| 05/10/2006 | EP1654265A1 N-heterocyclic carbenes that can be immobilized |
| 05/10/2006 | EP1654236A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 05/10/2006 | EP1654225A2 Melanin concentrating hormone receptor antagonists |
| 05/10/2006 | EP1359892B1 Primary intermediates for oxidative coloration of hair |
| 05/10/2006 | EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters |
| 05/10/2006 | CN1771087A Method for preparing bisphenol catalysts and bisphenols |
| 05/10/2006 | CN1769273A Meglumine glycididazole and its preparation method and uses as synergist of radiochemical therapy |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255385C Aphid alarm pheromone E-beta-Farmesene nitrogenous analog and its preparation method |
| 05/09/2006 | US7041834 alkylamination of N-methylcarbazol-5-one at the 6-position in the presence of formaldehyde, a secondary amine, and a desiccant; deamination and coupling of 2-methylimidazole at the 1-position; reaction time less than three hours |
| 05/09/2006 | US7041693 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |